New York, New York (PRWEB) October 02, 2013
Medidata Solutions and Spaulding Clinical Research were honored with the title of Disruptive Innovator of the Year at the Dpharm Disruptive Innovations conference on September 20, 2013 for their collaboration on a novel study evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community.
The 2nd Annual Quick Fire Disruptive Technology Presentations in an “American Idol /Shark Tank” format featured a number of innovators who were questioned and challenged by a panel of judges to determine how each technology was disruptive in advancing clinical development.
Randy Spaulding, Founder and CEO of Spaulding Clinical Research, gave a dynamic presentation alongside Glen de Vries, President of Medidata Solutions, to demonstrate how a study will integrate Spaulding’s cloud-based webECG™ Management Solution, Withings’ mHealth devices - which monitor physical activity and weight - and the Medidata Clinical Cloud™ to engage patients in their own care. Participants can relax while their data is captured at home using mHealth devices and made available to study coordinators through Spaulding and Medidata’s cloud-based technology. In addition, study participants will receive immediate feedback through the mHealth devices, which are wirelessly linked to targeted messaging for unique patient engagement.
Determining the most disruptive winner was the DPharm judging panel:
VP, Development Operations, Endo Pharmaceuticals
Jeff Kasher, PhD
VP, Clinical Trial: Materials, Implementation and Transformation, Eli Lilly
Andreas Koester, MD, PhD
VP, Clinical Trial Innovation & External Alliances, Janssen, Pharmaceutical Companies of Johnson & Johnson
Craig Lipset, MBA
Head of Clinical Innovation, Research & Development, Pfizer Inc.<
Copyright©2012 Vocus, Inc.
All rights reserved